Medtronic scores again: Robot Version of LigaSure RAS Obtains CE Certification

LigaSure RAS 

This certification further enhances the application capabilities of the Hugo system in multiple surgical procedures, including gynecology, urology, and general surgery, and fulfills Medtronic's commitment to integrating advanced closure technology into the robotic platform.

A doctor works at the console of the Medtronic Hugo robotic surgical system.

LigaSure is currently the most widely used advanced bipolar energy surgical sealing technology in the world. Since its launch, it has been used in over 35 million surgeries across 65 countries/regions. This technology can achieve precise closure of blood vessels, tissues, and lymphatic vessels under 7mm in about two seconds, while minimizing thermal spread to surrounding tissues, making it highly favored by surgeons.

LigaSure series products

The LigaSure RAS (Robotically Assisted Surgery) version that has obtained CE certification is specifically designed to be used with robotic-assisted surgery and can be connected to Medtronic's energy platform Valleylab FT10, further enhancing operational efficiency and closure safety in robotic surgery.

Surgeon Miguel Caceres from Panama Pacifica Salud Hospital stated, "LigaSure technology is one of the most significant advancements in minimally invasive surgery, giving us confidence in the safety of sealing. As robotic surgeons, we hope that the Hugo system will also have this technology."

Matt Anderson, Senior Vice President and President of Medtronic's Surgical business, pointed out: "The approval of LigaSure RAS is a key step in fulfilling our commitment. This is not just about technological integration, but also a positive reflection of our collaboration with surgical teams to shape the future of surgery together."

The Hugo system received its first CE certification in Europe in 2021 and has been implemented in over 30 countries worldwide. Medtronic stated that it expects to launch the Hugo system in the U.S. market by fiscal year 2026 (ending April 2026).

The indications for the procedure are urological surgeries, with plans to expand to gynecology and hernia among other fields.

In addition, Medtronic also plans to conduct remote surgery demonstrations based on the Hugo system and share the latest clinical data results of gynecological procedures at the recently held annual meeting of the Robotic Surgeons Association.